Changes in DNaseI hypersensitivity upon co-treatment of cells with Dex and E2
We report changes in DNaseI accessibility genome-wide upon co-treatment with Dex and E2 when compared to Dex or E2 treatments alone. Overall design: We examine ER and GR binding under four different treatments (unt, Dex, E2, and Dex + E2).